Cumberland Pharmaceuticals
Ifetroban for Treating DMD-Associated Cardiomyopathy
Feb 19, 2020 at 10:05 am by steve
Cumberland Pharmaceuticals Gears up for Phase II Clinical Trial
Last fall, the U.S. Food and Drug Administration (FDA) announced $15 million in grant funding in support of 12.... Read More
October 2024
Oct 16, 2024 at 10:27 pm by kbarrettalley
Your October 2024 Issue of Birmingham Medical News is Here!